JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Sirolimus as Therapeutic Approach to Uveitis

Phase 1

Completed

Conditions: Uveitis
Posterior Uveitis
Panuveitis
Intermediate Uveitis

Interventions: Drug: Sirolimus (rapamycin)

First Posted Date: 2009-05-25

Last Posted Date: 2018-08-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00908466

Locations: 🇺🇸
Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States

Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation

Not Applicable

Completed

Conditions: Overweight and Obesity

Interventions: Behavioral: ACHIEVE Intervention
Other: Control

First Posted Date: 2009-05-15

Last Posted Date: 2014-04-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 291

Registration Number: NCT00902694

Locations: 🇺🇸
Prohealth, Baltimore, Maryland, United States

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Early Phase 1

Completed

Conditions: Deep Venous Thrombosis
Pulmonary Embolism

Interventions: Drug: Enoxaparin
Drug: Fondaparinux

First Posted Date: 2009-05-06

Last Posted Date: 2019-06-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 198

Registration Number: NCT00894283

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

The Effect of Prescription Medications in Marijuana Users

Phase 1

Completed

Conditions: Marijuana Abuse

Interventions: Drug: Dronabinol 30mg/day
Drug: Dronabinol 60mg/day
Drug: Dronabinol 120mg/day
Drug: Placebo

First Posted Date: 2009-05-05

Last Posted Date: 2017-08-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT00893074

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep

Phase 1

Completed

Conditions: Marijuana Dependence

Interventions: Drug: eszopiclone
Drug: Placebo
Drug: ramelteon
Drug: zolpidem

First Posted Date: 2009-05-05

Last Posted Date: 2013-12-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 36

Registration Number: NCT00893269

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Incidence of Proximal Junctional Kyphosis (PJK) in Long Posterior Spinal Fusion: A Study Comparing Traditional Open Surgery to Minimally Invasive Percutaneous Technique at the Proximal Fusion Levels

Not Applicable

Completed

Conditions: Scoliosis
Kyphosis

Interventions: Procedure: Traditional technique
Procedure: Minimally invasive technique

First Posted Date: 2009-04-29

Last Posted Date: 2018-12-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 48

Registration Number: NCT00890227

Locations: 🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2009-04-29

Last Posted Date: 2018-03-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 670

Registration Number: NCT00889447

Locations: 🇺🇸
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States

Chronic Obstructive Pulmonary Disease (COPD) and Domestic Endotoxin (CODE)

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2009-04-29

Last Posted Date: 2019-06-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 84

Registration Number: NCT00890136

Locations: 🇺🇸
Karina Romero, Baltimore, Maryland, United States

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Itraconazole 200 mg
Drug: Itraconazole 300mg

First Posted Date: 2009-04-24

Last Posted Date: 2017-10-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 46

Registration Number: NCT00887458

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

and more 1 locations

Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy

Phase 1

Completed

Conditions: Urticaria

Interventions: Drug: abatacept (Orencia ®)

First Posted Date: 2009-04-23

Last Posted Date: 2016-01-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 4

Registration Number: NCT00886795

Locations: 🇺🇸
Johns Hopkins Arthritis Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy